Biological Products, (No Diagnostic Substances) Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Biological Products, (No Diagnostic Substances)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
100 results. Finviz
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company Name

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2025-10-17
ARTVArtiva Biotherapeutics, Inc.Aslan FredPres, CEOS - Sale$6.00-25,500356,721-7%-$153,000
2025-10-17
LXEOLexeo Therapeutics, Inc.See Tai SandiChief Development OfficerS - Sale$8.94-3,88865,862-6%-$34,767
2025-10-17
LXEOLexeo Therapeutics, Inc.Robertson JennyGCS - Sale$8.94-3,52668,930-5%-$31,530
2025-10-17
LXEOLexeo Therapeutics, Inc.Otero Jose ManuelChief Technical OfficerS - Sale$8.94-2,11564,197-3%-$18,913
2025-10-17
LXEOLexeo Therapeutics, Inc.Adler EricChief Medical OfficerS - Sale$8.94-3,38273,261-4%-$30,242
2025-10-17
LXEOLexeo Therapeutics, Inc.Townsend Richard NolanCEOS - Sale$8.94-13,133242,118-5%-$117,436
M
2025-10-15
VORVor Biopharma Inc.Reprogrammed Interchange LLC10%S - Sale$31.88-73,6761,204,442-6%-$2,348,744
M
2025-10-15
VORVor Biopharma Inc.Ra Capital Management, L.P.Dir, 10%S - Sale$29.54-464,02515,104-97%-$13,707,361
M
2025-10-15
VIRVir Biotechnology, Inc.Svf Endurance (Cayman) Ltd10%S - Sale$6.08-29,51515,340,4940%-$179,563
2025-10-15
GILDGilead Sciences, Inc.Dickinson Andrew DCFOS - Sale$118.08-2,500157,055-2%-$295,200
2025-10-15
GILDGilead Sciences, Inc.Mercier JohannaChief Commercial OfficerS - Sale$118.08-3,000110,193-3%-$354,240
2025-10-16
AURAAura Biosciences, Inc.Plavsic MarkCTOS - Sale$6.35-12,169197,287-6%-$77,273
2025-10-15
STROSutro Biopharma, Inc.Gerber Hans-PeterCHIEF SCIENTIFIC OFFICERP - Purchase$0.80+17,00071,832+31%+$13,607
2025-10-15
STROSutro Biopharma, Inc.Chow Gregory K.CFOP - Purchase$0.81+19,75019,750New+$15,998
2025-10-15
STROSutro Biopharma, Inc.Chung JaneCEOP - Purchase$0.80+12,500122,850+11%+$10,011
2025-10-15
STROSutro Biopharma, Inc.Matsui ConnieDirP - Purchase$0.80+50,00050,000New+$39,950
2025-10-15
STROSutro Biopharma, Inc.Pauling DavidChief Admin. Ofcr., GCP - Purchase$0.80+12,50471,737+21%+$9,993
2025-10-15
ACLXArcellx, Inc.Gilson MichelleCFOS - Sale$91.04-5,3648,466-39%-$488,315
M
2025-10-10
VORVor Biopharma Inc.Reprogrammed Interchange LLC10%S - Sale$31.08-96,6571,278,118-7%-$3,003,706
D
2025-10-14
CRSPCrispr Therapeutics AGKulkarni SamarthCEOS - Sale+OE$66.60-4,242290,758-1%-$282,517
D
2025-10-14
CRSPCrispr Therapeutics AGKasinger James R.GC, SecretaryS - Sale+OE$66.60-1,07683,402-1%-$71,662
D
2025-10-15
KYMRKymera Therapeutics, Inc.Gollob JaredChief Medical OfficerS - Sale+OE$61.42-59,576109,992-35%-$3,659,254
D
2025-10-13
RVMDRevolution Medicines, Inc.Kelsey Stephen MichaelSee RemarksS - Sale+OE$48.54-25,000284,047-8%-$1,213,540
D
2025-10-13
CGONCg Oncology, Inc.Post Leonard EDirS - Sale+OE$43.25-1,0000-100%-$43,250
2025-10-10
ZIVOZivo Bioscience, Inc.Yaldoo Laith LDir, 10%P - Purchase$12.05+1,659575,0950%+$19,991
D
2025-10-13
KYMRKymera Therapeutics, Inc.Gollob JaredChief Medical OfficerS - Sale+OE$60.00-3,114118,359-3%-$186,840
M
2025-10-09
VIRVir Biotechnology, Inc.Svf Endurance (Cayman) Ltd10%S - Sale$6.14-251,36015,370,009-2%-$1,543,899
D
2025-10-10
FENCFennec Pharmaceuticals Inc.Rallis Chris ADirS - Sale+OE$9.24-1,77557,079-3%-$16,401
2025-10-09
FDMT4D Molecular Therapeutics, Inc.Bizily ScottGCS - Sale$10.00-2,4085,188-32%-$24,080
D
2025-10-13
KYMRKymera Therapeutics, Inc.Albers Jeffrey W.DirS - Sale+OE$59.19-5,0000-100%-$295,949
M
2025-10-08
CGEMCullinan Therapeutics, Inc.Lynx1 Capital Management LP10%P - Purchase$6.73+1,459,64116,194,827+10%+$9,826,941
2025-10-09
RGNXRegenxbio Inc.Simpson CurranCEOS - Sale$12.62-20,811216,162-9%-$262,635
D
2025-10-10
RXRXRecursion Pharmaceuticals, Inc.Gibson ChristopherCEOS - Sale+OE$6.04-100,000954,229-9%-$604,000
M
2025-10-08
VORVor Biopharma Inc.Reprogrammed Interchange LLC10%S - Sale$33.16-124,1461,374,775-8%-$4,116,369
D
2025-10-09
CGONCg Oncology, Inc.Mulay JamesDirS - Sale+OE$43.99-5,9030-100%-$259,673
M
2025-10-08
TWSTTwist Bioscience CorpLaponis AdamCFOS - Sale$31.96-5,51791,525-6%-$176,315
2025-10-08
IMVTImmunovant, Inc.Geffner MichaelChief Medical OfficerS - Sale$16.30-1,272220,553-1%-$20,734
2025-10-08
IMVTImmunovant, Inc.Stout Jay SCTOS - Sale$16.30-1,585203,334-1%-$25,836
M
2025-10-08
ATYRAtyr Pharma IncSchimmel PaulDirP - Purchase$0.91+1,000,0002,101,056+91%+$911,801
M
2025-10-07
FENCFennec Pharmaceuticals Inc.Southpoint Capital Advisors LP10%S - Sale$9.48-67,1144,010,100-2%-$636,229
2025-10-07
INBXInhibrx Biosciences, Inc.Viking Global Investors LP10%S - Sale$32.25-350,000102,864-77%-$11,287,500
M
2025-10-07
VIRVir Biotechnology, Inc.Svf Endurance (Cayman) Ltd10%S - Sale$5.99-538,37515,621,369-3%-$3,223,939
2025-10-08
ZIVOZivo Bioscience, Inc.Maggiore Christopher D.Dir, 10%P - Purchase$12.01+23,682517,526+5%+$284,421
M
2025-10-06
VORVor Biopharma Inc.Reprogrammed Interchange LLC10%S - Sale$36.12-98,3871,498,921-6%-$3,553,499
2025-10-06
TWSTTwist Bioscience CorpLaponis AdamCFOS - Sale$32.19-5,87597,042-6%-$189,099
D
2025-10-06
TWSTTwist Bioscience CorpLeproust Emily M.CEOS - Sale+OE$32.19-31,348601,212-5%-$1,008,998
2025-10-06
TWSTTwist Bioscience CorpWerner Robert F.Chief Accounting OfficerS - Sale$32.19-2,04146,413-4%-$65,694
2025-10-06
TWSTTwist Bioscience CorpGreen PaulaSVP of HRS - Sale$32.19-9,724114,678-8%-$312,986
2025-10-06
TWSTTwist Bioscience CorpFinn Patrick JohnPres, COOS - Sale$32.19-23,747208,735-10%-$764,345
2025-10-06
TWSTTwist Bioscience CorpCho DennisSee RemarksS - Sale$32.19-3,87698,710-4%-$124,757
2025-10-07
MGTXMeiragtx Holdings PlcForbes AlexandriaPres, CEOS - Sale$8.39-47,5001,313,983-3%-$398,525
M
2025-10-03
SRRKScholar Rock Holding CorpAkkaraju SrinivasDirP - Purchase$37.58+500,4395,824,381+9%+$18,807,352
2025-10-03
VYGRVoyager Therapeutics, Inc.Jorgensen Nathan D.CFOS - Sale$4.78-7,666123,834-6%-$36,643
M
2025-10-03
VIRVir Biotechnology, Inc.Svf Endurance (Cayman) Ltd10%S - Sale$5.57-524,29716,159,744-3%-$2,922,426
M
2025-10-03
ACLXArcellx, Inc.Gilson MichelleCFOS - Sale$86.04-5,94613,830-30%-$511,603
2025-10-06
FENCFennec Pharmaceuticals Inc.Raykov RostyDirS - Sale$9.78-10,00082,501-11%-$97,800
2025-10-02
TWSTTwist Bioscience CorpCho DennisSee RemarksS - Sale$29.16-124102,5860%-$3,616
2025-10-02
TWSTTwist Bioscience CorpGreen PaulaSVP of HRS - Sale$29.16-140124,4020%-$4,083
D
2025-10-02
TWSTTwist Bioscience CorpLeproust Emily M.CEOS - Sale+OE$29.16-476632,5600%-$13,881
2025-10-02
TWSTTwist Bioscience CorpFinn Patrick JohnPres, COOS - Sale$29.16-206232,4820%-$6,007
M
2025-10-01
VORVor Biopharma Inc.Reprogrammed Interchange LLC10%S - Sale$39.43-41,7521,597,308-3%-$1,646,237
D
2025-10-01
APGEApogee Therapeutics, Inc.Dambkowski CarlChief Medical OfficerS - Sale+OE$39.80-5,110284,733-2%-$203,378
DM
2025-10-01
HALOHalozyme Therapeutics, Inc.Torley HelenPres, CEOS - Sale+OE$71.86-60,000733,719-8%-$4,311,745
2025-10-01
DNAGinkgo Bioworks Holdings, Inc.Coen Steven P.See remarksS - Sale$15.00-5,6095,503-50%-$84,135
D
2025-08-08
ASMBAssembly Biosciences, Inc.Gilead Sciences, Inc.10%P - Purchase$0.00+2,295,9204,505,391+104%+$0
2025-10-01
BEAMBeam Therapeutics Inc.Cavanagh Bethany JSVP, Finance, TreasurerS - Sale$24.53-46744,045-1%-$11,456
2025-10-01
BEAMBeam Therapeutics Inc.Bellon ChristineGCS - Sale$24.53-373116,9210%-$9,150
DM
2025-10-01
BEAMBeam Therapeutics Inc.Evans John M.CEOS - Sale+OE$24.57-50,0001,089,667-4%-$1,228,323
2025-09-30
ZIVOZivo Bioscience, Inc.Yaldoo Laith LDir, 10%P - Purchase$15.99+15,322573,436+3%+$244,999
2025-09-30
LENZLenz Therapeutics, Inc.Versant Venture Capital Vi, L.P.10%S - Sale$46.01-224,9742,656,888-8%-$10,352,017
D
2025-09-30
IMCRImmunocore Holdings PlcBerman David MHEAD OF R, DS - Sale+OE$35.23-61,8490-100%-$2,178,940
2025-10-01
VIRVir Biotechnology, Inc.Sato Vicki LDirS - Sale$5.84-22,0001,232,391-2%-$128,396
2025-10-01
HALOHalozyme Therapeutics, Inc.Connaughton BernadetteDirS - Sale$75.24-2,00044,952-4%-$150,481
D
2025-09-30
CGONCg Oncology, Inc.Post Leonard EDirS - Sale+OE$40.09-5,0000-100%-$200,450
2025-09-29
RGNXRegenxbio Inc.Simpson CurranCEOS - Sale$10.03-7,624236,973-3%-$76,469
2025-09-30
ACLXArcellx, Inc.Heery ChristopherCHIEF MEDICAL OFFICERS - Sale$81.28-21,034624-97%-$1,709,723
2025-09-29
GILDGilead Sciences, Inc.O'Day Daniel PatrickCOB, CEOS - Sale$111.66-10,000591,203-2%-$1,116,564
D
2025-09-29
CGONCg Oncology, Inc.Mulay JamesDirS - Sale+OE$39.19-12,7550-100%-$499,868
2025-09-26
DTILPrecision Biosciences IncFrankel StanleyDirP - Purchase$4.97+2,70016,778+19%+$13,419
2025-09-29
ACLXArcellx, Inc.Heery ChristopherCHIEF MEDICAL OFFICERS - Sale$80.16-7321,6580%-$5,852
2025-09-23
FDMT4D Molecular Therapeutics, Inc.Bizily ScottGCS - Sale$8.00-2,4077,596-24%-$19,256
2025-09-26
ACLXArcellx, Inc.Heery ChristopherCHIEF MEDICAL OFFICERS - Sale$80.12-12,39621,731-36%-$993,155
D
2025-09-25
RXRXRecursion Pharmaceuticals, Inc.Gibson ChristopherCEOS - Sale+OE$4.76-100,000954,229-9%-$476,000
2025-09-24
RVMDRevolution Medicines, Inc.Cislini JeffGCS - Sale$44.26-1,79950,425-3%-$79,624
2025-09-24
TARSTarsus Pharmaceuticals, Inc.Azamian Bobak R.Pres, CEO, Board ChairS - Sale$55.37-6,000865,741-1%-$332,220
2025-09-23
SMNRSemnur Pharmaceuticals, Inc.Scilex Holding Co10%S - Sale$16.00-12,500,000188,554,849-6%-$200,000,000
2025-09-22
SRRKScholar Rock Holding CorpQatanani MoCHIEF SCIENTIFIC OFFICERS - Sale$30.67-3,353108,964-3%-$102,846
2025-09-22
TWSTTwist Bioscience CorpCho DennisSee RemarksS - Sale$27.56-233102,7100%-$6,421
2025-09-22
TWSTTwist Bioscience CorpGreen PaulaSVP of HRS - Sale$27.56-295124,5420%-$8,130
D
2025-09-22
TWSTTwist Bioscience CorpLeproust Emily M.CEOS - Sale+OE$27.56-1,704633,0360%-$46,962
D
2025-09-22
JSPRJasper Therapeutics, Inc.Wiggans Thomas GDirP - Purchase$2.43+41,00046,000+820%+$99,630
D
2025-09-22
JSPRJasper Therapeutics, Inc.Lucas SvetlanaDirP - Purchase$2.43+20,00020,000New+$48,600
D
2025-09-22
JSPRJasper Therapeutics, Inc.Martell RonPres, CEOP - Purchase$2.43+41,00074,118+124%+$99,630
D
2025-09-22
JSPRJasper Therapeutics, Inc.Shizuru Judith AnneDirP - Purchase$2.43+41,000156,901+35%+$99,630
2025-09-22
DTILPrecision Biosciences IncBrown MelindaDirP - Purchase$4.89+1,40021,965+7%+$6,846
2025-09-22
HALOHalozyme Therapeutics, Inc.Labrosse NicoleSVP, CFOS - Sale$77.95-2,22722,079-9%-$173,584
D
2025-09-19
BCDABiocardia, Inc.Stertzer Simon HDirP - Purchase$1.25+398,400714,275+126%+$498,000
D
2025-09-19
BCDABiocardia, Inc.Blank Andrew ScottDirP - Purchase$1.25+288,000636,058+83%+$360,000
D
2025-09-19
BCDABiocardia, Inc.Altman PeterPres, CEOP - Purchase$1.25+48,000216,762+28%+$60,000
2025-09-18
LENZLenz Therapeutics, Inc.Versant Venture Capital Vi, L.P.10%S - Sale$42.23-135,3042,881,862-4%-$5,714,356

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top